COVID-19 is causing a renaissance in the UK biotech sector, we must ensure it lasts
pharmaphorum
AUGUST 27, 2020
Over the past five to ten years US investors have focused on technology and internet companies, and relatively little on new biotech or pharmaceutical companies. The first is that the development of vaccines is utilising cutting edge technologies. This precision has significant advantages in efficacy and production.
122 
Let's personalize your content